Vives F - Search Results

1

Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the L-dopa.

Agil A, Durán R, Barrero F, Morales B, Araúzo M, Alba F, Miranda MT, Prieto I, Ramírez M, Vives F. Agil A, et al. Among authors: vives f. J Neurol Sci. 2006 Jan 15;240(1-2):31-6. doi: 10.1016/j.jns.2005.08.016. Epub 2005 Oct 10. J Neurol Sci. 2006. PMID: 16219327 Clinical Trial.

2

Plasma alpha-synuclein in patients with Parkinson's disease with and without treatment.

Duran R, Barrero FJ, Morales B, Luna JD, Ramirez M, Vives F. Duran R, et al. Among authors: vives f. Mov Disord. 2010 Mar 15;25(4):489-93. doi: 10.1002/mds.22928. Mov Disord. 2010. PMID: 20063406

3

Oxidative stress and plasma aminopeptidase activity in Huntington's disease.

Duran R, Barrero FJ, Morales B, Luna JD, Ramirez M, Vives F. Duran R, et al. Among authors: vives f. J Neural Transm (Vienna). 2010 Mar;117(3):325-32. doi: 10.1007/s00702-009-0364-0. Epub 2010 Jan 22. J Neural Transm (Vienna). 2010. PMID: 20094738

4

Oxidative stress and aminopeptidases in Parkinson's disease patients with and without treatment.

Duran R, Barrero FJ, Morales B, Luna JD, Ramirez M, Vives F. Duran R, et al. Among authors: vives f. Neurodegener Dis. 2011;8(3):109-16. doi: 10.1159/000315404. Epub 2010 Aug 12. Neurodegener Dis. 2011. PMID: 20714110

5

[Proteomic biomarkers in Parkinson's disease].

Bandrés S, Durán R, Barrero F, Ramírez M, Vives F. Bandrés S, et al. Among authors: vives f. Rev Neurol. 2014 Feb 16;58(4):166-74. Rev Neurol. 2014. PMID: 24504879 Free article. Review. Spanish.

6

Saposin C, Key Regulator in the Alpha-Synuclein Degradation Mediated by Lysosome.

Ruz C, Barrero FJ, Pelegrina J, Bandrés-Ciga S, Vives F, Duran R. Ruz C, et al. Among authors: vives f. Int J Mol Sci. 2022 Oct 9;23(19):12004. doi: 10.3390/ijms231912004. Int J Mol Sci. 2022. PMID: 36233303 Free PMC article.

7

Plasma aminopeptidase activities in Parkinson's disease.

Banegas I, Barrero F, Durán R, Morales B, Luna JD, Prieto I, Ramírez M, Alba F, Vives F. Banegas I, et al. Among authors: vives f. Horm Metab Res. 2006 Nov;38(11):758-60. doi: 10.1055/s-2006-955088. Horm Metab Res. 2006. PMID: 17111304

8

Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1).

Barrero FJ, Ampuero I, Morales B, Vives F, de Dios Luna Del Castillo J, Hoenicka J, García Yébenes J. Barrero FJ, et al. Among authors: vives f. Pharmacogenomics J. 2005;5(2):135-41. doi: 10.1038/sj.tpj.6500301. Pharmacogenomics J. 2005. PMID: 15668727

9

Plasma aminopeptidase activities in rats after left and right intrastriatal administration of 6-hydroxydopamine.

Banegas I, Prieto I, Vives F, Alba F, Duran R, Segarra AB, de Gasparo M, Ramírez M. Banegas I, et al. Among authors: vives f. Neuroendocrinology. 2004;80(4):219-24. doi: 10.1159/000082748. Epub 2004 Dec 13. Neuroendocrinology. 2004. PMID: 15604601

10

Lateralized response of oxytocinase activity in the medial prefrontal cortex of a unilateral rat model of Parkinson's disease.

Banegas I, Prieto I, Vives F, Alba F, de Gasparo M, Duran R, Segarra AB, Ramírez M. Banegas I, et al. Among authors: vives f. Behav Brain Res. 2010 Dec 1;213(2):328-31. doi: 10.1016/j.bbr.2010.05.030. Epub 2010 May 24. Behav Brain Res. 2010. PMID: 20576539

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page